In summary, Analyst Group views the agreement with Apotera as an important milestone in Nosa Plugs’ establishment in Norway and a confirmation of the Company’s growing relevance as a partner to leading pharmacy chains following the acquisition of Pharmacure. The launch highlights the strength of Nosa Plugs’ expanded product portfolio and supports the Company’s strategy to further grow its consumer business across Europe. Analyst Group assesses that the collaboration with Apotera will strengthen brand visibility and sales in the Nordic region and serve as a platform for additional market launches going forward.

Read Analyst Group’s comment here

About Analyst Group: One of the Nordic’s leading analysis houses with a focus on small and medium-sized listed companies.
Read more about Analyst Group

This is a press release from Analyst Group regarding the publication of an equity research report on Nosa Plugs. Readers may assume that Analyst Group has received compensation for making the equity research report. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation, or anything else that could be considered a subjective assessment.